| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.67B | +28.8% |
| Cost of Revenue | $378.7M | +23.4% |
| Gross Profit | $1.29B | +30.4% |
| R&D Expense | $421.4M | +17.7% |
| SG&A Expense | $278.5M | +27.8% |
| Operating Income | -$154.8M | +16.6% |
| Pre-tax Income | -$70.9M | +60.2% |
| Income Tax | $7.9M | +30.3% |
| Net Income | -$78.8M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $147.7M | +70.0% |
| Accounts Receivable | $316.8M | +27.6% |
| Current Assets | $2.27B | +14.4% |
| Total Assets | $3.30B | +19.6% |
| Current Liabilities | $793.7M | +40.0% |
| Total Liabilities | $2.25B | +12.9% |
| Stockholders' Equity | $1.05B | +37.1% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $380.4M | +49.5% |
| Capital Expenditures | $185.0M | +61.8% |
| Investing Cash Flow | -$330.2M | -77.3% |
| Financing Cash Flow | $12.8M | +106.7% |
| Free Cash Flow | $195.4M | +39.6% |
| +57.2% |
| EPS (Basic) | -$0.23 | +58.2% |
| EPS (Diluted) | -$0.23 | +58.2% |